Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Mayer Institute is a private Canadian healthcare organization focused on evidence-based diabetic foot wound care, prevention, and patient education. Based in Hamilton, Ontario, it operates as a specialty care provider rather than a drug-development biotech company, offering clinical treatment, consulting, and educational services for patients with diabetes-related foot complications. Public descriptions characterize the organization as a center of excellence in diabetic foot care led by Dr. Perry Mayer. The institute emphasizes preventative care, multidisciplinary management, and limb-salvage oriented treatment approaches, and it also participates in clinical and outcomes-focused research related to lower-limb ulcers and wound healing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Mayer Institute.